Given IL-11 is known to play a significant role in the production of osteoclasts from progenitor cells in the bone marrow, the invasion of metastatic breast cancer cells commonly leads to bone destruction though the signaling actions of IL-11 and parathyroid hormone-related protein (PTHrP) released from tumor cells to activate osteoclasts [69]. The gene discussed is IL11; the disease is breast cancer.